Clinical Trial Update: A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for GEn-1124 in subjects with acute respiratory distress syndrome, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• GEn-1124

Snippet

Sponsor: GEn1E Lifesciences | Conditions: Respiratory Distress Syndrome, Acute | Phase 2 | Status: RECRUITING